A comprehensive introduction to the value that strong relationships with patient advocacy groups bring to pharmaceutical companies. This document bundles several database documents, including 4262, 4265, 4431 and 3626 – spanning three separate research initiatives from Best Practices LLC. Topics covered include how companies select patient advocacy groups and organize activities with them. Documents show examples of when relationships with patient advocacy groups can help further a company’s efforts such as in communicating the results of clinical trials and in assisting with drug development efforts. Case studies also detail lessons learned from past patient advocacy partnerships. The information in this document will help readers understand pharmaceutical industry best practices for working with patient advocacy groups.